Secondary Logo

Journal Logo

Most Popular Articles

Intratumoral injection of radioactive holmium-166 microspheres in recurrent head and neck squamous cell carcinoma: preliminary results of first use

Bakker, Robbert C.; van Es, Robert J.J.; Rosenberg, Antoine J.W.P.; More

Nuclear Medicine Communications. 39(3):213-221, March 2018.

Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma

George, Sally L.; Falzone, Nadia; Chittenden, Sarah; More

Nuclear Medicine Communications. 37(5):466-472, May 2016.

Evaluation of drug effects on cerebral blood flow and glucose uptake in un-anesthetized and un-stimulated rats: application of free-moving apparatus enabling to keep rats free during PET/SPECT tracer injection and uptake

Sugita, Taku; Kondo, Yusuke; Ishino, Seigo; More

Nuclear Medicine Communications. 39(8):753-760, August 2018.

18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis

Kouijzer, Ilse J.E.; Berrevoets, Marvin A.H.; Aarntzen, Erik H.J.G.; More

Nuclear Medicine Communications. 39(8):747-752, August 2018.

Quantitative assessment of 18F-FDG PET in patients with Hodgkin lymphoma: is it significantly affected by contrast-enhanced computed tomography attenuation correction?

Voltin, Conrad-Amadeus; Mettler, Jasmin; Boellaard, Ronald; More

Nuclear Medicine Communications. 40(3):249-257, March 2019.

Semi-quantitative F-18-FDG PET/computed tomography parameters for prediction of grade in patients with renal cell carcinoma and the incremental value of diuretics

Singh, Harpreet; Arora, Geetanjali; Nayak, Brusabhanu; More

Nuclear Medicine Communications. 41(5):485-493, May 2020.

The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes

Uyama, Naoto; Otsuka, Hideki; Shinya, Takayoshi; More

Nuclear Medicine Communications. 38(6):487-492, June 2017.

Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging

Ortiz-Arzate, Zareth; Santos-Cuevas, Clara L.; Ocampo-García, Blanca E.; More

Nuclear Medicine Communications. 35(4):423-432, April 2014.

Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson’s disease

Okada, Yukinori; Shiraishi, Makoto; Nakamura, Hisao; More

Nuclear Medicine Communications. 39(11):983-988, November 2018.

Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumors

Weber, Manuel; Kessler, Lukas; Schaarschmidt, Benedikt; More

Nuclear Medicine Communications. 41(4):363-369, April 2020.

Redox reaction and clinical outcome of primary diffuse large B-cell lymphoma of the central nervous system: Prognostic role of metabolic and textural parameters of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/computed tomography in a small patient cohort

Tsuchiya, Junichi; Yoneyama, Tomohiro; Ohtake, Makoto; More

Nuclear Medicine Communications. 41(6):567-574, June 2020.

Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non–small cell lung cancer patients

Shi, Yun-Mei; Niu, Rong; Shao, Xiao-Liang; More

Nuclear Medicine Communications. 41(5):459-468, May 2020.

Hypoxia imaging with [18F]HX4 PET in squamous cell head and neck cancers: a pilot study for integration into treatment planning

Betts, Helen M.; O’Connor, Richard A.; Christian, Judith A.; More

Nuclear Medicine Communications. 40(1):73-78, January 2019.

InfuShield: a shielded enclosure for administering therapeutic radioisotope treatments using standard syringe pumps

Rushforth, Dominic P.; Pratt, Brenda E.; Chittenden, Sarah J.; More

Nuclear Medicine Communications. 38(3):266-272, March 2017.

Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma

Huang, Honghui; Xiao, Fei; Han, Xiaofeng; More

Nuclear Medicine Communications. 37(7):689-698, July 2016.

Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology

Castellucci, Paolo; Perrone, Anna M.; Picchio, Maria; More

Nuclear Medicine Communications. 28(8):589-595, August 2007.

Comparison between anatomical cross-sectional imaging and 18F-FDG PET/CT in the staging, restaging, treatment response, and long-term surveillance of squamous cell head and neck cancer: a systematic literature overview

Evangelista, Laura; Cervino, Anna Rita; Chondrogiannis, Sotirios; More

Nuclear Medicine Communications. 35(2):123-134, February 2014.

Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow

Özde, Cem; Aktüre, Gülsah; Aytekin, Seda; More

Nuclear Medicine Communications. 40(11):1122-1129, November 2019.

Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: a prospective evaluation of 89 healthy adults

Blomberg, Björn A.; Thomassen, Anders; de Jong, Pim A.; More

Nuclear Medicine Communications. 38(11):998-1006, November 2017.

Tc-99m-MAA lung shunt fraction before Y-90 radioembolization is low among patients with non-hepatocellular carcinoma malignancies

Elsayed, Mohammad; Martin, Jonathan G.; Dabrowiecki, Alexander; More

Nuclear Medicine Communications. 40(11):1154-1157, November 2019.

Additional value of combining low-dose computed tomography to V/Q SPECT on a hybrid SPECT-CT camera for pulmonary embolism diagnosis

Le Roux, Pierre-Yves; Robin, Philippe; Delluc, Aurélien; More

Nuclear Medicine Communications. 36(9):922-930, September 2015.

Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma

Anongpornjossakul, Yoch; Sriwatcharin, Wattanun; Thamnirat, Kanungnij; More

Nuclear Medicine Communications. 41(4):336-343, April 2020.